1. Heo DS (2002) Progress and limitations in cancer gene therapy. Genet Med 4(6 Suppl):52S–55S
2. Tamura RE, de Vasconcellos JF, Sarkar D, Libermann TA, Fisher PB, Zerbini LF (2012) GADD45 proteins: central players in tumorigenesis. Curr Mol Med 12(5):634–651
3. Hollander MC, Kovalsky O, Salvador JM, Kim KE, Patterson AD, Haines DC, Fornace AJ Jr (2001) Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res 61(6):2487–2491
4. Hollander MC, Fornace AJ (2002) Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a. Oncogene 21(40):6228–6233
5. Jiang T, Soprano DR, Soprano KJ (2007) GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells. J Cell Physiol 212(3):771–779